663 related articles for article (PubMed ID: 29199704)
41. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
[TBL] [Abstract][Full Text] [Related]
42. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
Deppen S; Putnam JB; Andrade G; Speroff T; Nesbitt JC; Lambright ES; Massion PP; Walker R; Grogan EL
Ann Thorac Surg; 2011 Aug; 92(2):428-32; discussion 433. PubMed ID: 21592456
[TBL] [Abstract][Full Text] [Related]
43. The value of 18F-FDG PET/CT in the diagnosis of different size of solitary pulmonary nodules.
Tang K; Wang L; Lin J; Zheng X; Wu Y
Medicine (Baltimore); 2019 Mar; 98(11):e14813. PubMed ID: 30882661
[TBL] [Abstract][Full Text] [Related]
44. 18F-FDG-PET/CT versus 99Tcm-MIBI-SPECT: which is better for detection of solitary pulmonary nodules ?
Xia G; An C; Ming Z; Guo H; Liu L; Li Y
J BUON; 2017; 22(5):1246-1251. PubMed ID: 29135109
[TBL] [Abstract][Full Text] [Related]
45. What is the clinical value of PET/CT in the diagnosis of pulmonary nodules?
Lohrmann C; Weber WA
Zentralbl Chir; 2014 Feb; 139(1):108-13. PubMed ID: 24585199
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of the solitary pulmonary nodule by positron emission tomography imaging.
Bury T; Dowlati A; Paulus P; Corhay JL; Benoit T; Kayembe JM; Limet R; Rigo P; Radermecker M
Eur Respir J; 1996 Mar; 9(3):410-4. PubMed ID: 8729997
[TBL] [Abstract][Full Text] [Related]
47. Risk stratification of solitary pulmonary nodules by means of PET using (18)F-fluorodeoxyglucose and SUV quantification.
Grgic A; Yüksel Y; Gröschel A; Schäfers HJ; Sybrecht GW; Kirsch CM; Hellwig D
Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1087-94. PubMed ID: 20140611
[TBL] [Abstract][Full Text] [Related]
48. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.
Halley A; Hugentobler A; Icard P; Porret E; Sobrio F; Lerochais JP; Bouvard G; Zalcman G; Agostini D
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1026-32. PubMed ID: 15877227
[TBL] [Abstract][Full Text] [Related]
49. A model of malignant risk prediction for solitary pulmonary nodules on
Yu M; Wang Z; Yang G; Cheng Y
Thorac Cancer; 2020 May; 11(5):1211-1215. PubMed ID: 32162769
[TBL] [Abstract][Full Text] [Related]
50. Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.
Ohno Y; Kishida Y; Seki S; Yui M; Miyazaki M; Koyama H; Yoshikawa T
J Magn Reson Imaging; 2018 Apr; 47(4):1013-1021. PubMed ID: 28799280
[TBL] [Abstract][Full Text] [Related]
51. Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients.
Schillaci O; Travascio L; Bolacchi F; Calabria F; Bruni C; Cicciò C; Guazzaroni M; Orlacchio A; Simonetti G
Radiol Med; 2009 Sep; 114(6):890-906. PubMed ID: 19579015
[TBL] [Abstract][Full Text] [Related]
52. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
53.
Ruhlmann M; Ruhlmann J; Görges R; Herrmann K; Antoch G; Keller HW; Ruhlmann V
Thyroid; 2017 Oct; 27(10):1300-1306. PubMed ID: 28793848
[TBL] [Abstract][Full Text] [Related]
54. The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer.
Kagna O; Solomonov A; Keidar Z; Bar-Shalom R; Fruchter O; Yigla M; Israel O; Guralnik L
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):997-1004. PubMed ID: 19194704
[TBL] [Abstract][Full Text] [Related]
55. Comparison of quantitatively analyzed dynamic area-detector CT using various mathematic methods with FDG PET/CT in management of solitary pulmonary nodules.
Ohno Y; Nishio M; Koyama H; Fujisawa Y; Yoshikawa T; Matsumoto S; Sugimura K
AJR Am J Roentgenol; 2013 Jun; 200(6):W593-602. PubMed ID: 23701089
[TBL] [Abstract][Full Text] [Related]
56. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
[TBL] [Abstract][Full Text] [Related]
57. Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.
Khalaf M; Abdel-Nabi H; Baker J; Shao Y; Lamonica D; Gona J
J Hematol Oncol; 2008 Sep; 1():13. PubMed ID: 18808716
[TBL] [Abstract][Full Text] [Related]
58. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
59. The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT.
Naalsund A; Maublant J
Respiration; 2006; 73(5):634-41. PubMed ID: 16679755
[TBL] [Abstract][Full Text] [Related]
60. Risk-related
Spadafora M; Pace L; Evangelista L; Mansi L; Del Prete F; Saladini G; Miletto P; Fanti S; Del Vecchio S; Guerra L; Pepe G; Peluso G; Nicolai E; Storto G; Ferdeghini M; Giordano A; Farsad M; Schillaci O; Gridelli C; Cuocolo A
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1908-1914. PubMed ID: 29730697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
